PHARMAQ FISHTEQ AS

8700 NESNA

Finances

Return on Equity

−181,68 %

Current Ratio

0,9

Debt-to-Equity Ratio

0,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	48 879 000	49 277 000	44 171 000	19 198 000
Net Income	−21 117 000	−2 742 000	5 077 000	−616 000
Total Assets	68 312 000	71 510 000	58 191 000	26 648 000
Total Equity	11 623 000	12 807 000	13 923 000	7 660 000

Income (NOK)	2022	2021	2020	2019
Revenue	48 879 000	49 277 000	44 171 000	19 198 000
Expenditure	68 247 000	51 938 000	38 990 000	19 926 000
Operating Profit	−26 281 000	−2 660 000	5 181 000	−728 000
Financial Income	530 000	667 000	1 593 000	27 000
Financial Costs	1 296 000	1 497 000	266 000	89 000
Financial Balance	−766 000	−830 000	1 327 000	−62 000
Earnings Before Tax	−27 048 000	−3 491 000	6 508 000	−789 000
Tax	−5 931 000	−748 000	1 431 000	−174 000
Net Income	−21 117 000	−2 742 000	5 077 000	−616 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	17 567 000	42 387 000	41 869 000	21 246 000
Total Current Assets	50 745 000	29 123 000	16 321 000	5 402 000
Total Assets	68 312 000	71 510 000	58 191 000	26 648 000
Total Retained Equity	0	11 096 000	13 838 000	7 575 000
Total Equity	11 623 000	12 807 000	13 923 000	7 660 000
Total Long-Term Debt	277 000	586 000	875 000	901 000
Total Current Debt	56 412 000	58 117 000	43 392 000	18 086 000
Total Equity and Debt	68 312 000	71 510 000	58 191 000	26 648 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	48 879 000	49 277 000	43 887 000	19 198 000
Other Income	0	0	284 000	0
Revenue	48 879 000	49 277 000	44 171 000	19 198 000
Cost of Goods Sold	5 773 000	5 587 000	6 505 000	0
Salary Costs	22 620 000	20 895 000	16 484 000	9 657 000
Depreciation	4 157 000	4 714 000	5 088 000	3 867 000
Impairment	25 075 000	0	0	0
Expenditure	68 247 000	51 938 000	38 990 000	19 926 000
Operating Profit	−26 281 000	−2 660 000	5 181 000	−728 000
Financial Income	530 000	667 000	1 593 000	27 000
Financial Costs	1 296 000	1 497 000	266 000	89 000
Financial Balance	−766 000	−830 000	1 327 000	−62 000
Dividends	0	0	0	0
Net Income	−21 117 000	−2 742 000	5 077 000	−616 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	14 547 000	39 482 000	38 856 000	18 651 000
Fixtures	339 000	224 000	332 000	948 000
Total Tangible Assets	14 886 000	39 706 000	39 188 000	19 599 000
Total Fiancial Fixed Assets	2 681 000	2 681 000	2 681 000	1 647 000
Total Fixed Assets	17 567 000	42 387 000	41 869 000	21 246 000
Stock	14 229 000	15 980 000	5 733 000	0
Total Investments	0	0	0	0
Cash, Bank	0	0	0	827 000
Total Current Assets	50 745 000	29 123 000	16 321 000	5 402 000
Total Assets	68 312 000	71 510 000	58 191 000	26 648 000
Total Equity	11 623 000	12 807 000	13 923 000	7 660 000
Short-Term Group Debt	0	0	0	16 106 000
Total Long-Term Debt	277 000	586 000	875 000	901 000
Creditors	281 000	649 000	402 000	34 000
Unpaid Taxes	1 008 000	1 052 000	792 000	442 000
Dividends	0	0	0	0
Other Current Debt	55 123 000	56 416 000	40 596 000	1 505 000
Total Current Debt	56 412 000	58 117 000	43 392 000	18 086 000
Total Equity and Debt	68 312 000	71 510 000	58 191 000	26 648 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−181,68 %	−21,41 %	36,46 %	−8,04 %
Debt-to-Equity Ratio	0,02	0,05	0,06	0,12
Operating Profit Margin	−53,77 %	−5,4 %	11,73 %	−3,79 %
Current Ratio	0,9	0,5	0,38	0,3
Quick Ratio	1,2	0,69	0,43	0,3
Equity Ratio	0,17	0,18	0,24	0,29
Gross Profit Margin	88,19 %	88,66 %	85,27 %	100 %